Security key
12674W109
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 7,500
- Total 13F value
- $23,000
- Share change
- +7,500
- SEC-reported price per share
- $3.07
- Number of holders
- 1
- Value change
- +$23,000
- Number of buys
- 1
- Shares outstanding
- 212,877,018
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
CABA full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Cabaletta Bio, Inc. SEC filings
Cabaletta Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 12674W109
Recent filing periods:
Ownership snapshot
Top reported holders of CABA - Cabaletta Bio, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JENNISON ASSOCIATES LLC
Disclosed value leader
JENNISON ASSOCIATES LLC
Comparable rows
15/15
Latest evidence
31 May 2026
13D/G
13F
3/4/5
Lead comparable stake: 11%
13D/G row: JENNISON ASSOCIATES LLC
Showing 1-6 of 15 holder rows.
Quick read
JENNISON ASSOCIATES LLC leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JENNISON ASSOCIATES LLC's linked filing trail.
Comparable ownership
Top 5
JENNISON ASSOCIATES LLC
11%
PRUDENTIAL FINANCIAL INC
11%
T. Rowe Price Investment Manageme...
10%
Bain Capital Life Sciences Opport...
10%
Adage Capital Management, L.P.
10%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC |
13D/G
13F
Company
|
11%
|
$88,092,767
24,267,980 shares
|
+$42,410,898 | 29 May 2026 |
| PRUDENTIAL FINANCIAL INC |
13D/G
|
11%
|
$88,092,767
24,267,980 shares
|
+$42,410,898 | 31 May 2026 |
| T. Rowe Price Investment Management, Inc. |
13F
13D/G
Company
|
10%
from 13D/G
|
$29,806,000
11,080,005 shares
|
— | 31 Mar 2026 |
| Bain Capital Life Sciences Opportunities III, LP |
13D/G
|
10%
|
$15,483,400
9,677,125 shares
|
$0 | 30 Jun 2025 |
| Adage Capital Management, L.P. |
13D/G
|
10%
|
$14,404,128
9,002,580 shares
|
$0 | 30 Jun 2025 |
| Cormorant Asset Management, LP |
13D/G
13F
Company
|
9%
|
$31,605,000
10,500,000 shares
|
+$3,311,000 | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
7,500
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
107
Q2 2026 holders
1
Holder diff
-106
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend